Title: A Comparative Study in Patients with Fibromyalgia Receiving Probiotics Along with Standard Therapy
Authors: Athul P.N, Densy C Daniel, Muhammed Yaseen, Mrs. Jereena. E, Dr K.A. Rasheed
DOI: https://dx.doi.org/10.18535/jmscr/v7i9.108
Abstract
Background: The present study was done to determine the impact of gut microbiome in altering the symptoms of fibromyalgia..
Aim: To study the benefits of adding probiotics along with standard therapy in fibromyalgia.
Materials and Methods: A total of 104 patients aged 20-65 were included in this study. The patients were divided into two groups, Case (N=52) and Control (N=52). The Case group received Bacillus subtilis probiotic (10 billion CFU’s) along with Amitriptyline (10mg), whereas the Control group received Amitriptyline alone (10mg). The patients were evaluated 14 days after baseline, and then monthly for six months. Assessment of patients was done with the help of the Visual Analog Scale (VAS) and the Revised Fibromyalgia Impact Questionnaire (FIQR).
Results: Significant improvement was observed in both groups after ten weeks of treatment (p<0.05). Percentage reduction in VAS –Pain score, FIQR-Pain score, and the FIQR- Total score was slightly higher in the case group compared to that of control (difference of approximately 2%). However, the percentage reduction in the FIQR-Sleep quality score showed a greater improvement in the Case group to that of control (difference of approximately 23%).
Conclusion: Both groups showed significant improvement in pain, functional status and neuropsychological symptoms; however, the addition of probiotics as an adjuvant to standard therapy showed additional improvement in pain, functional status, and sleep quality. Consequently, based on results obtained, probiotics can be used as an adjuvant in the management of Fibromyalgia.
Keywords: Fibromyalgia, amitriptyline, probiotics, Bacillus subtilis.
References
- Supraha V, Francis DK, Utrobicic A, Choy H, Tenzera D, Kordic A. Probiotics for fibromyalgia. The Cochrane Library. 2013.
- Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J. Harrison's Principles of Internal Medicine 18E Vol 2 EB. McGraw Hill Professional; 2012 Nov 8.
- Acet G, Kaya A, Akturk S, Akgol G. A comparison of the effectiveness of amitriptyline and pregabalin treatment in fibromyalgia patients. Northern Clinics of Istanbul. 2017;4(2):151.
- Grimm V, Riedel C. Manipulation of the Microbiota Using Probiotics. Microbiota of the Human Body.2016; 109-117.
- Galland L. The gut microbiome and the brain. Journal of medicinal food. 2014 Dec 1;17(12):1261-72.
- Lee WJ, Hase K. Gut microbiota-generated metabolites in animal health and disease. Nature Chemical Biology. 2014
- Shanahan F. The host-microbe interface within the gut. Bailliere’s Best Practice and Research in Clinical Gastroenterology. 2002.
- Bercik P, Collins SM, Verdu EF. Microbes and the gut-brain axis. Neurogastroent-erology and Motility. 2012.
- Foster JA, McVey Neufeld KA. Gut-brain axis: How the microbiome influences anxiety and depression. Trends in Neurosciences. 2013.
- Clapp M, Aurora N, Herrera L, Bhatia M, Wilen E, Wakefield S. Gut microbiota’s effect on mental health: the gut-brain axis. Clin Pract. 2017;
- Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The revised fibromyalgia impact questionnaire (FIQR): Validation and psychometric properties. Arthritis Res Ther.2009.